| 1 |
35083771 | Statin treatment effectiveness and the SLCO1B1*5 reduced function genotype: Long-term outcomes in women and men. | 2022 Jul |
3 |
| 2 |
33027917 | The Association of 3-Hydroxy-3-Methylglutaryl-CoA Reductase, Apolipoprotein E, and Solute Carrier Organic Anion Genetic Variants with Atorvastatin Response among Jordanian Patients with Type 2 Diabetes. | 2020 Oct 5 |
1 |
| 3 |
29405807 | Interaction of deoxyschizandrin and schizandrin B with liver uptake transporters OATP1B1 and OATP1B3. | 2019 Feb |
1 |
| 4 |
28435225 | Association of genetic variations with pharmacokinetics and lipid-lowering response to atorvastatin in healthy Korean subjects. | 2017 |
1 |
| 5 |
28482130 | Candidate-Gene Study of Functional Polymorphisms in SLCO1B1 and CYP3A4/5 and the Cholesterol-Lowering Response to Simvastatin. | 2017 May |
3 |
| 6 |
25379722 | Function-impairing polymorphisms of the hepatic uptake transporter SLCO1B1 modify the therapeutic efficacy of statins in a population-based cohort. | 2015 Jan |
2 |
| 7 |
23436703 | Gene-gene-environment interactions between drugs, transporters, receptors, and metabolizing enzymes: Statins, SLCO1B1, and CYP3A4 as an example. | 2013 Sep |
1 |
| 8 |
21902813 | Gender, but not CYP7A1 or SLCO1B1 polymorphism, affects the fasting plasma concentrations of bile acids in human beings. | 2012 Mar |
3 |
| 9 |
22189199 | Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly. | 2012 Feb |
1 |
| 10 |
22352740 | Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity. | 2012 Apr 2 |
2 |
| 11 |
22505549 | SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians. | 2012 Mar |
2 |
| 12 |
22016628 | Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response. | 2011 |
1 |
| 13 |
20220747 | Pharmacokinetic and pharmacodynamic interactions between the immunosuppressant sirolimus and the lipid-lowering drug ezetimibe in healthy volunteers. | 2010 Jun |
1 |
| 14 |
20712525 | Pharmacogenetic interactions between ABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in the prevention of myocardial infarction. | 2010 Aug |
1 |
| 15 |
19530968 | Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. | 2009 Jun |
2 |
| 16 |
18794729 | Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate. | 2008 Oct |
4 |
| 17 |
17439540 | SLCO1B1 521T-->C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients. | 2007 Sep |
1 |
| 18 |
16568260 | Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levels. | 2006 Apr |
2 |
| 19 |
16917677 | Pharmacogenetic determinants of variability in lipid-lowering response to pravastatin therapy. | 2006 |
1 |
| 20 |
17108811 | SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid. | 2006 Dec |
1 |
| 21 |
15864131 | Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17. | 2005 May |
5 |